Stephan Busque MD
Transplantation
Professor, Surgery - Multi-Organ Transplantation, Stanford University Medical Center
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Busque is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Montreal Faculty of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1993 - 2026
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
- Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Start of enrollment: 2004 Jul 01
- Comparative Renal Function of Young (18-45 Years) and Ageing (55 Years and Above) Kidney Donors Start of enrollment: 2003 Mar 01
Publications & Presentations
PubMed
- Highly sensitized pediatric kidney candidates have reduced access to kidney transplant in the United States.Toshihiro Nakayama, Daniel J Ahn, Antony Attia, Kliment K Bozhilov, Varvara A Kirchner
American Journal of Transplantation. 2026-05-15 - Donor-Targeted Anti-HLA-A2 Antibody Shows Nanogram-Level Efficacy in a Novel GVHD Mouse Model.Kouta Niizuma, Alyssa H Chang, Jeewon S Kim, Stephan Busque, Ravindra Majeti
Biorxiv. 2025-07-19 - 9 citationsInduction of immune tolerance in living related human leukocyte antigen-matched kidney transplantation: A phase 3 randomized clinical trial.Dixon B Kaufman, Sanjeev K Akkina, Mark D Stegall, James B Piper, A Osama Gaber
American Journal of Transplantation. 2025-07-01
Journal Articles
- Review Macrochimerism and Clinical Transplant ToleranceSamuel Strober, Stephan Busque, Edgar Engleman, Robert Lowsky, John D Scandling, Judith Shizuru, ScienceDirect
Press Mentions
Medeor Therapeutics to Provide Interim Results of Phase 3 Mercury Study of MDR-101 Cell Therapy in Living Donor Kidney Transplants During Rapid Fire Oral Presentation at ATC Virtual CongressMay 20th, 2021
Annual Awards Honor Outstanding Teaching, Patient CareJune 22nd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
